AlphAIAlphAI — Financial news for AI agents
aol.comAUG 263 min read$EL

Estée Lauder (EL) Q4 2026 Earnings Call Transcript

Estée Lauder (EL) reported 3% organic net sales growth for fiscal 2026, with adjusted EPS of $2.51, up 66%. Key drivers included 10% fragrance sales growth and 9% growth in Mainland China. Guidance for fiscal 2027 includes 3-5% organic sales growth and adjusted EPS of $3.10-$3.35. Management highlighted margin expansion and strategic initiatives, including headcount reductions and digital investments.

Original reporting
aol.com
Published Aug 26, 2026, 3:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 3:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Estée Lauder (EL) Q4 2026 Earnings Call Transcript — source image
Source · aol.com
Decision brief

The 30-second read

$ELBullishHigh
01

Why it matters

The earnings beat and forward guidance are likely to drive short‑term buying interest and could trigger sector rotation into beauty and luxury stocks.

02

Market read

EL's strong results and optimistic guidance make the story highly relevant for traders focused on consumer discretionary and luxury beauty stocks.

03

What to watch

Headcount reductions and restructuring costs may mask underlying operational challenges.

Relevance 9/10Novelty 9/10Timing: post‑earnings release

Background

The transcript summarizes Estée Lauder's FY2026 earnings call, covering financial results, segment performance, and FY2027 outlook.

Company-level read

Ticker impact

$ELBullishHigh confidence
Context

Estée Lauder reported FY2026 organic net sales growth of 3% and provided FY2027 guidance on sales, margin and EPS.

Expected impact

Potential price appreciation as investors price in higher margins and EPS guidance.

Evidence & confidence

The company delivered 66% EPS growth, margin expansion, and raised FY2027 EPS guidance, which are material new data for a large-cap consumer discretionary stock.

Market effects

Sector

Positive earnings may lift peer luxury cosmetics stocks and reinforce confidence in consumer discretionary sector.

Regional

Strong China sales growth could boost sentiment toward other consumer brands with exposure to Mainland China.

Global

Large‑cap earnings beat influences broader market indices and may affect weightings in consumer discretionary ETFs.

Counterpoint

What could challenge this read

Guidance assumes continued macro stability; any slowdown in China or higher input costs could pressure margins.

Key entities

  • company
    Estée Lauder Companies Inc.

    US‑listed consumer‑goods company (ticker EL) reporting FY2026 results.

Read at source← All news

Related articles

SEP 15
$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

investing.com2 min
AUG 28
$ELHighAI 8/10

Estée Lauder (EL)’s China Bet Just Paid Off. Its Makeup Business Still Hasn’t Caught Up

Estée Lauder (EL) reported Q4 net sales of $3.63B, up 6.3%, driven by luxury fragrance and skincare. It forecasted fiscal 2027 adjusted EPS of $3.10-$3.35, above estimates, sending shares up 11% premarket. However, makeup sales were flat, and hair care dropped 1%. The company also reported a $38M tariff-refund benefit and a net loss of $116M, down from $546M a year earlier.

yahoo.com2 min
AUG 28
$ELMedAI 8/10

Estee Lauder vs Nike: One Turnaround Just Proved Itself, the Other Keeps Slipping

Estee Lauder (EL) reported four consecutive earnings beats, raising its fiscal 2027 EPS guidance to $3.10-$3.35. Nike (NKE) guided revenue down, with Greater China down 12% and Converse down 32%. EL's stock rose 10.46% post-earnings, while NKE's turnaround timeline extends. EL's forward P/E is near 32, with a 1.3% yield. NKE offers a 4.3% yield but faces declining revenue.

aol.com3 min
AUG 27
$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

baystreet.ca2 min
AUG 27
$ELHighAI 8/10

Estée Lauder’s (EL) Turnaround Story Just Got Real Numbers Behind It

Estée Lauder (EL) reported fiscal 2026 Q4 and full-year earnings, showing organic net sales up 3%, adjusted operating margin at 11.2%, and adjusted diluted EPS at $2.51. Fragrance and Skin Care led growth, with Jo Malone and TOM FORD joining the billion-dollar brand club. The company guided fiscal 2027 organic sales growth of 3% to 5% and adjusted operating margin of 12.7% to 13.5%. Challenges include Middle East conflict impacts and Hair Care declines. Hedge fund ownership held steady at 47 fun

insidermonkey.com3 min
AUG 26
$ELMedAI 8/10

5 Insightful Analyst Questions From Estée Lauder’s Q2 Earnings Call

Estée Lauder (EL) reported Q2 revenue of $3.64 billion, beating estimates, with organic revenue up 5%. Adjusted EPS was $0.39, also topping forecasts. Management cited strong sales across regions and product categories, particularly in Skin Care and Fragrance, and operational improvements. Despite a GAAP loss, cost control and market share gains were highlighted. Analysts questioned margin outlook, organic sales growth, and regional strategies, with management providing detailed responses. EL st

financialcontent.com3 min